Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

Colorcon
AstraZeneca
McKesson
Medtronic
Moodys
Johnson and Johnson

Last Updated: October 18, 2019

DrugPatentWatch Database Preview

TOBRAMYCIN Drug Profile

See Plans and Pricing

« Back to Dashboard

When do Tobramycin patents expire, and what generic alternatives are available?

Tobramycin is a drug marketed by Alcon Pharms Ltd, Alembic Pharms Ltd, Apotex Inc, Bausch And Lomb, Fera Pharms, Somerset Theraps Llc, Akorn Inc, Amneal Pharms, Dr Reddys Labs Sa, Lupin, Mylan, Teva Pharms Usa, Akorn, Apothecon, Baxter Hlthcare Corp, Fresenius Kabi Usa, Hospira, Igi Labs Inc, Mylan Labs Ltd, Watson Labs Inc, West-ward Pharms Int, X Gen Pharms, and Xellia Pharms Aps. and is included in forty-one NDAs.

The generic ingredient in TOBRAMYCIN is tobramycin sulfate. There are eighteen drug master file entries for this compound. Eight suppliers are listed for this compound. Additional details are available on the tobramycin sulfate profile page.

Drug patent expirations by year for TOBRAMYCIN
Drug Prices for TOBRAMYCIN

See drug prices for TOBRAMYCIN

Drug Sales Revenue Trends for TOBRAMYCIN

See drug sales revenues for TOBRAMYCIN

Recent Clinical Trials for TOBRAMYCIN

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Sutphin DrugsEarly Phase 1
University of DundeePhase 2
Maisonneuve-Rosemont HospitalPhase 1

See all TOBRAMYCIN clinical trials

Recent Litigation for TOBRAMYCIN

Identify potential future generic entrants

District Court Litigation
Case NameDate
Chiesi U.S.A., Inc. v. Teva Pharmaceuticals USA, Inc.2017-12-07
Novartis AG v. Lee2013-01-14
NOVARTIS AG v. KAPPOS2011-05-03

See all TOBRAMYCIN litigation

Pharmacology for TOBRAMYCIN
Medical Subject Heading (MeSH) Categories for TOBRAMYCIN
Synonyms for TOBRAMYCIN
(1S,2S,3R,4S,6R)-4,6-diamino-3-(2,6-diamino-2,3,6-trideoxy-alpha-D-ribo-hexopyranosyloxy)-2-hydroxycyclohexyl 3-amino-3-deoxy-alpha-D-glucopyranoside
(1S,2S,3R,4S,6R)-4,6-diamino-3-[(2,6-diamino-2,3,6-trideoxy-alpha-D-ribo-hexopyranosyl)oxy]-2-hydroxycyclohexyl 3-amino-3-deoxy-alpha-D-glucopyranoside
(2S,3R,4S,5S,6R)-4-amino-2-(((1S,2S,3R,4S,6R)-4,6-diamino-3-(((2R,3R,5S,6R)-3-amino-6-(aminomethyl)-5-hydroxytetrahydro-2H-pyran-2-yl)oxy)-2-hydroxycyclohexyl)oxy)-6-(hydroxymethyl)tetrahyd
(2S,3R,4S,5S,6R)-4-amino-2-(((1S,2S,3R,4S,6R)-4,6-diamino-3-(((2R,3R,5S,6R)-3-amino-6-(aminomethyl)-5-hydroxytetrahydro-2H-pyran-2-yl)oxy)-2-hydroxycyclohexyl)oxy)-6-(hydroxymethyl)tetrahydro-2H-pyran-3,5-diol
(2S,3R,4S,5S,6R)-4-amino-2-((1S,2S,3R,4S,6R)-4,6-diamino-3-((2R,3R,5S,6R)-3-amino-6-(aminomethyl)-5-hydroxytetrahydro-2H-pyran-2-yloxy)-2-hydroxycyclohexyloxy)-6-(hydroxymethyl)tetrahydro-2H-pyran-3,5-diol
(2S,3R,4S,5S,6R)-4-amino-2-[(1S,2S,3R,4S,6R)-4,6-diamino-3-[(2R,3R,5S,6R)-3-amino-6-(aminomethyl)-5-hydroxy-tetrahydropyran-2-yl]oxy-2-hydroxy-cyclohexoxy]-6-(hydroxymethyl)tetrahydropyran-3,5-diol
(2S,3R,4S,5S,6R)-4-amino-2-[(1S,2S,3R,4S,6R)-4,6-diamino-3-[(2R,3R,5S,6R)-3-amino-6-(aminomethyl)-5-hydroxyoxan-2-yl]oxy-2-hydroxycyclohexyl]oxy-6-(hydroxymethyl)oxane-3,5-diol
(2S,3R,4S,5S,6R)-4-amino-2-{[(1S,2S,3R,4S,6R)-4,6-diamino-3-{[(2R,3R,5S,6R)-3-amino-6-(aminomethyl)-5-hydroxyoxan-2-yl]oxy}-2-hydroxycyclohexyl]oxy}-6-(hydroxymethyl)oxane-3,5-diol
1-Epitobramycin
11098-01-4
11111-45-8
3'-Deoxykanamycin B
32986-56-4
34337-51-4
37321-13-4
4-(2,6-Diamino-2,3,6-trideoxy-alpha-D-glycopyranosyl)-6-(3-amino-3-deoxy-alpha-D-glycopyranosyl)-2-deoxystreptamine
4-AMINO-2-[4,6-DIAMINO-3-(3-AMINO-6-AMINOMETHYL-5-HYDROXY-TETRAHYDRO-PYRAN-2-YLOXY)-2-HYDROXY-CYCLOHEXYLOXY]-6-HYDROXYMETHYL-TETRAHYDRO-PYRAN-3,5-DIOL
49842-07-1 (Sulfate)
54330-95-9
70322-33-7
986T564
A-8891
AB00052438_13
AB00052438_14
AB00052438-12
AB00513858
AB2000616
AC1L1VI0
AC1Q2AOW
AKOS016339662
Aktob
AN-9578
AOB5629
API0004434
BDBM50366778
Bethkis
Bethkis (TN)
BIDD:GT0503
BIT0802
BPBio1_000647
BRD-K05619559-001-12-7
BRN 1357507
Brulamycin
BSPBio_000587
BSPBio_002036
C-22669
C00397
C18H37N5O9
CAS-32986-56-4
CC-35084
CCG-39936
CHEBI:28864
CHEMBL1747
CPD000058793
CS-2547
D-Streptamine, O-3-amino-3-deoxy-.alpha.-D-glucopyranosyl-(1->6)-O-[2,6-diamino-2,3,6-trideoxy-.alpha.-D-ribo-hexopyranosyl-(1->4)]-2-deoxy-
D-Streptamine, O-3-amino-3-deoxy-.alpha.-D-glucopyranosyl-(1->6)-O-[2,6-diamino-2,3,6-trideoxy-.alpha.-D-ribohexopyranosyl-(1->4)]-2-deoxy-
D-Streptamine, O-3-amino-3-deoxy-alpha-D-glucopyranosyl-(1->6)-O-(2,6-diamino-2,3,6-trideoxy-alpha-D-ribo-hexopyranosyl-(1->4))-2-deoxy-
D-Streptamine, O-3-amino-3-deoxy-alpha-D-glucopyranosyl-(1-6)-O-(2,6-diamino-2,3,6-trideoxy-alpha-D-ribo-hexopyranosyl-(1-4))-2-deoxy-
D00063
DB00684
Deoxykanamycin B
Distobram
DSSTox_CID_3680
DSSTox_GSID_23680
DSSTox_RID_77144
DTXSID8023680
EINECS 251-322-5
Gernebcin
Gotabiotic
HMS2090B16
HMS2092M17
HMS2096N09
HMS3713N09
HSDB 3259
HY-B0441
J10405
KBio2_001552
KBio2_004120
KBio2_006688
KBio3_001536
KBioGR_001104
KBioSS_001552
Kitabis Pak
KS-1405
Lilly 47663
LS-146940
LS-187329
MFCD00077885
MLS000069544
MolPort-003-665-548
NCGC00016814-01
NCGC00178852-01
NCGC00178852-02
Nebcin
Nebcin (Sulfate)
Nebicin
NEBRAMYCIN
Nebramycin 6
Nebramycin factir 6
Nebramycin factor 6
Nebramycin VI
Nebramycin-Faktor 6
NLVFBUXFDBBNBW-PBSUHMDJSA-N
NSC 180514
NSC-757352
NSC757352
O-[3-Amino-3-deoxy-alpha-D-glucopyranosyl-(1-->6)]-O-[2,6-diamino-2,3,6-trideoxy-alpha-D-ribohexopyranosyl-(1-->4)]-2-deoxy-D-streptamine
O-[3-Amino-3-deoxy-alpha-D-glucopyranosyl-(1->6)]-O-[2,6-diamino-2,3,6-trideoxy-alpha-D-ribo-hexopyranosyl-(1->4)]-2-deoxy-D-streptamine
O-3-Amino-3-deoxy-?-D-glucopyranosyl-(1-6)-O-[2,6-diamino-2,3,6-trideoxy-?-D-ribohexopyranosyl-(1-4)]-2-deoxy-D-streptamine
O-3-Amino-3-deoxy-a-D-glucopyranosyl-(1-6)-O-[2,6-diamino-2,3,6-trideoxy-a -D-ribo-hexopyranosyl-(1-4)]-2-deoxy-D-streptamine
O-3-Amino-3-deoxy-alpha-D-glucopyranosyl-(1-4)-O-(2,6-diamino-2,3,6-trideoxy-alpha-D-ribo-hexopyranosyl-(1-6))-2-deoxy-L-streptamine
O-3-Amino-3-deoxy-alpha-D-glucopyranosyl-(1-4)-O-(2,6-diamino-2,3,6-trideoxy-alpha-D-ribohexopyranosyl-(1-4))-2-deoxy-D-streptamine
O-3-Amino-3-deoxy-alpha-D-glucopyranosyl-(1-6)-O-(2,6-diamino-2,3,6-trideoxy-alpha-D-ribohexopyranosyl-(1-4))-2-deoxy-D-streptamine
Obramycin
Pharmakon1600-01500579
Prestwick3_000544
Q-201837
ro-2H-pyran-3,5-diol
s2514
SAM001246911
SBI-0051915.P003
SC-45657
SCHEMBL2838
SMR000058793
SPBio_000295
Spectrum_001072
SPECTRUM1500579
Spectrum2_000078
Spectrum3_000588
Spectrum4_000752
Spectrum5_001038
SPRC-AB01
SR-01000721898
SR-01000721898-2
SR-05000001726
SR-05000001726-1
SR-05000001726-2
Streptamine, O-3-amino-3-deoxy-alpha-D-glucopyranosyl-(1-4)-O-(2,6-diamino-2,3,6-trideoxy-alpha-D-ribohexopyranosyl-(1-6))-2-deoxy-, D-
Streptamine, O-3-amino-3-deoxy-alpha-D-glucopyranosyl-(1-4)-O-(2,6-diamino-2,3,6-tyrideoxy-alpha-D-ribohexopyranosyl-(1-6))-2-deoxy-, D-
Sybryx
Tenebrimycin
Tenemycin
TOA-(1-6)2TB-(4-1)TOC
TOA-(1-6)TOB-(4-1)TOC
Tobacin
Tobi
Tobi (TN)
Tobi Podhaler
Tobracin
Tobracin (TN)
Tobradex
Tobradistin
Tobralex
Tobramaxin
Tobramicin
Tobramicina
Tobramicina [INN-Spanish]
Tobramitsetin
Tobramycetin
Tobramycin (JP17/USP)
Tobramycin [2M+H]
Tobramycin [USAN:BAN:INN:JAN]
Tobramycin [USAN:USP:INN:BAN:JAN]
Tobramycin Base
Tobramycin for Inhalation
tobramycin solution for inhalation
TOBRAMYCIN SULFATE
Tobramycin, 97%
Tobramycin, Antibiotic for Culture Media Use Only
Tobramycin,(S)
Tobramycine
Tobramycine [INN-French]
Tobramycinum
Tobramycinum [INN-Latin]
Tobrased
Tobrasone
Tobrex
Tobrex (TN)
torbamycin
Tox21_110626
TOY
UNII-NQJ13I4Z9U component NLVFBUXFDBBNBW-PBSUHMDJSA-N
UNII-VZ8RRZ51VK
VZ8RRZ51VK
ZINC8214692
ZX-AFC000193

US Patents and Regulatory Information for TOBRAMYCIN

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Xellia Pharms Aps TOBRAMYCIN SULFATE tobramycin sulfate INJECTABLE;INJECTION 205685-001 Sep 16, 2014 AP RX No No   Start Trial   Start Trial   Start Trial
Teva Pharms Usa TOBRAMYCIN SULFATE tobramycin sulfate INJECTABLE;INJECTION 063100-001 Jan 30, 1992 AP RX No No   Start Trial   Start Trial   Start Trial
Hospira TOBRAMYCIN SULFATE IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER tobramycin sulfate INJECTABLE;INJECTION 063081-006 Jun 2, 1993 RX No Yes   Start Trial   Start Trial   Start Trial
Igi Labs Inc TOBRAMYCIN SULFATE tobramycin sulfate INJECTABLE;INJECTION 063120-001 Oct 31, 1994 DISCN No No   Start Trial   Start Trial   Start Trial
Watson Labs Inc TOBRAMYCIN SULFATE tobramycin sulfate INJECTABLE;INJECTION 062945-001 Aug 9, 1989 DISCN No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Moodys
AstraZeneca
Mallinckrodt
Merck
McKinsey
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.